52 related articles for article (PubMed ID: 36151009)
1. Novel Approaches to Thyroid Cancer Treatment and Response Assessment.
Grewal RK; Ho A; Schöder H
Semin Nucl Med; 2016 Mar; 46(2):109-18. PubMed ID: 26897715
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer: burden of illness and management of disease.
Brown RL; de Souza JA; Cohen EE
J Cancer; 2011 Apr; 2():193-9. PubMed ID: 21509149
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine treatment of differentiated thyroid cancer despite history of 'iodine allergy'.
Puchalski AR; Chopra IJ
Endocrinol Diabetes Metab Case Rep; 2014; 2014():130084. PubMed ID: 24683486
[TBL] [Abstract][Full Text] [Related]
4. Surgical decision making in the management of well-differentiated thyroid cancer.
Chernichenko N; Shaha AR
Indian J Surg Oncol; 2012 Sep; 3(3):161-5. PubMed ID: 23997503
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration.
Sun YQ; Sun D; Zhang X; Zhang YQ; Lin YS
Front Endocrinol (Lausanne); 2022; 13():994288. PubMed ID: 36531486
[TBL] [Abstract][Full Text] [Related]
6. Radioactive Iodine in Differentiated Carcinoma of Thyroid: An Overview.
Singh NK; Ramamourthy B; Hage N; Nagaraju S; Kappagantu KM
Curr Radiopharm; 2024; 17(1):2-6. PubMed ID: 37877561
[TBL] [Abstract][Full Text] [Related]
7. Exploring the oral-gut microbiota during thyroid cancer: Factors affecting the thyroid functions and cancer development.
Kun Y; Xiaodong W; Haijun W; Xiazi N; Dai Q
Food Sci Nutr; 2023 Oct; 11(10):5657-5674. PubMed ID: 37823092
[TBL] [Abstract][Full Text] [Related]
8. Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
Juweid ME; Tulchinsky M; Mismar A; Momani M; Zayed AA; Al Hawari H; Albsoul N; Mottaghy FM
Int J Cancer; 2020 Nov; 147(9):2345-2354. PubMed ID: 32319676
[TBL] [Abstract][Full Text] [Related]
9. The evolving use of radioiodine therapy in differentiated thyroid cancer.
Mayson SE; Yoo DC; Gopalakrishnan G
Oncology; 2015; 88(4):247-56. PubMed ID: 25503797
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine therapy in the different stages of differentiated thyroid cancer.
Valerio L; Maino F; Castagna MG; Pacini F
Best Pract Res Clin Endocrinol Metab; 2023 Jan; 37(1):101703. PubMed ID: 36151009
[TBL] [Abstract][Full Text] [Related]
11. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.
Tuttle RM; Tala H; Shah J; Leboeuf R; Ghossein R; Gonen M; Brokhin M; Omry G; Fagin JA; Shaha A
Thyroid; 2010 Dec; 20(12):1341-9. PubMed ID: 21034228
[TBL] [Abstract][Full Text] [Related]
12. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
13. Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Dehbi HM; Mallick U; Wadsley J; Newbold K; Harmer C; Hackshaw A
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):44-51. PubMed ID: 30501974
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems.
Pitoia F; Bueno F; Urciuoli C; Abelleira E; Cross G; Tuttle RM
Thyroid; 2013 Nov; 23(11):1401-7. PubMed ID: 23517313
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
